Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

Open Access 01-05-2011 | Original Article

^99mTc-besilesomab (Scintimun®) in peripheral osteomyelitis: comparison with ^99mTc-labelled white blood cells

Authors: Wolf S. Richter, Velimir Ivancevic, Johannes Meller, Otto Lang, Dominique Le Guludec, István Szilvazi, Holger Amthauer, Florence Chossat, Amel Dahmane, Carsten Schwenke, Alberto Signore

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2011

Abstract

Purpose

The diagnosis of osteomyelitis is a challenge for diagnostic imaging. Nuclear medicine procedures including white blood cell imaging have been successfully used for the identification of bone infections. This multinational, phase III clinical study in 22 European centres was undertaken to compare anti-granulocyte imaging using the murine IgG antibody besilesomab (Scintimun®) with ^99mTc-labelled white blood cells in patients with peripheral osteomyelitis.

Methods

A total of 119 patients with suspected osteomyelitis of the peripheral skeleton received ^99mTc-besilesomab and ^99mTc-hexamethylpropyleneamine oxime (HMPAO)-labelled white blood cells (WBCs) in random order 2–4 days apart. Planar images were acquired at 4 and 24 h after injection. All scintigraphic images were interpreted in an off-site blinded read by three experienced physicians specialized in nuclear medicine, followed by a fourth blinded reader for adjudication. In addition, clinical follow-up information was collected and a final diagnosis was provided by the investigators and an independent truth panel. Safety data including levels of human anti-mouse antibodies (HAMA) and vital signs were recorded.

Results

The agreement in diagnosis across all three readers between Scintimun® and ^99mTc-HMPAO-labelled WBCs was 0.83 (lower limit of the 95% confidence interval 0.8). Using the final diagnosis of the local investigator as a reference, Scintimun® had higher sensitivity than ^99mTc-HMPAO-labelled WBCs (74.8 vs 59.0%) at slightly lower specificity (71.8 vs 79.5%, respectively). All parameters related to patient safety (laboratory data, vital signs) did not provide evidence of an elevated risk associated with the use of Scintimun® except for two cases of transient hypotension. HAMA were detected in 16 of 116 patients after scan (13.8%).

Conclusion

Scintimun® imaging is accurate, efficacious and safe in the diagnosis of peripheral bone infections and provides comparable information to ^99mTc-HMPAO-labelled WBCs.

Available only for authorised users

http://www.leukokit.com/home.htm

http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001045/WC500075575.pdf

Concia E, Prandini N, Massari L, Ghisellini F, Consoli V, Menichetti F, et al. Osteomyelitis: clinical update for practical guidelines. Nucl Med Commun 2006;27:645–60.PubMedCrossRef

Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med 2009;39:66–78.PubMedCrossRef

Chatha DS, Cunningham PM, Schweitzer ME. MR imaging of the diabetic foot: diagnostic challenges. Radiol Clin North Am 2005;43:747–59. ix.PubMedCrossRef

Gnanasegaran G, Chicklore S, Vijayanathan S, O’Doherty MJ, Fogelman I. Diabetes and bone: advantages and limitations of radiological, radionuclide and hybrid techniques in the assessment of diabetic foot. Minerva Endocrinol 2009;34:237–54.PubMed

Rozzanigo U, Tagliani A, Vittorini E, Pacchioni R, Brivio LR, Caudana R. Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis. Radiol Med 2009;114:121–32.PubMedCrossRef

Rojas-Burke J. Health officials reacting to infection mishaps. J Nucl Med 1992;33:13N–4N. 27N.

de Vries EF, Roca M, Jamar F, Israel O, Signore A. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging 2010;37:842–8.PubMedCrossRef

Schwenke C, Busse R. Analysis of differences in proportions from clustered data with multiple measurements in diagnostic studies. Methods Inf Med 2007;46:548–52.PubMed

Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 2005;87:2464–71.PubMedCrossRef

10.

Steinsträsser A, Berberich R, Kuhlmann L, Zabori S, Schwarz A. Binding of the monoclonal antibody BW 250/183 to human granulocytes. Nuklearmedizin 1992;31:57–63.PubMed

11.

Bosslet K, Steinsträsser A, Schwarz A, Harthus HP, Lüben G, Kuhlmann L, et al. Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur J Nucl Med 1988;14:523–8.PubMedCrossRef

12.

Morguet AJ, Munz DL, Ivancević V, Werner GS, Sandrock D, Bökemeier M, et al. Immunoscintigraphy using technetium-99m-labeled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J Am Coll Cardiol 1994;23:1171–8.PubMedCrossRef

13.

Morguet AJ, Munz DL, Ivancević V, Werner GS, Kreuzer H. The clinical importance of scintigraphy with the murine monoclonal antigranulocyte antibody BW 250/183 for the diagnosis of prosthesis-related endocarditis. Dtsch Med Wochenschr 1995;120:861–6.PubMedCrossRef

14.

Segarra I, Roca M, Baliellas C, Vilar L, Ricart Y, Mora J, et al. Granulocyte-specific monoclonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labelled leucocyte scintigraphy in inflammatory bowel disease. Eur J Nucl Med 1991;18:715–9.PubMedCrossRef

15.

Papos M, Nagy F, Narai G, Rajtar M, Szantai G, Lang J, et al. Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease. Dig Dis Sci 1996;41:412–20.PubMedCrossRef

16.

Almers S, Granerus G, Franzén L, Ström M. Technetium-99m scintigraphy: more accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies. Eur J Nucl Med 1996;23:247–55.PubMedCrossRef

17.

Tarján Z, Tóth G, Györke T, Mester A, Karlinger K, Makó EK. Ultrasound in Crohn’s disease of the small bowel. Eur J Radiol 2000;35:176–82.PubMedCrossRef

18.

Peltier P, Potel G, Lovat E, Baron D, Chatal JF. Detection of lung and bone infection with anti-granulocyte monoclonal antibody BW 250/183 radiolabelled with 99Tcm. Nucl Med Commun 1993;14:766–74.PubMedCrossRef

19.

Kroiss A, Sporn P, Auinger C, Redl E, Böck F, Dinstl K, et al. Immunoscintigraphy for detection of inflammatory perioperative foci. Acta Med Austriaca 1993;20:45–9.PubMed

20.

Becker W, Dölkemeyer U, Gramatzki M, Schneider MU, Scheele J, Wolf F. Use of immunoscintigraphy in the diagnosis of fever of unknown origin. Eur J Nucl Med 1993;20:1078–83.PubMedCrossRef

21.

Meller J, Ivancevic V, Conrad M, Gratz S, Munz DL, Becker W. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med 1998;39:1248–53.PubMed

22.

Gratz S, Behr TM, Herrmann A, Meller J, Conrad M, Zappel H, et al. Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin. Nucl Med Commun 1998;19:1037–45.PubMedCrossRef

23.

Graute V, Feist M, Lehner S, Haug A, Müller PE, Bartenstein P, et al. Detection of low-grade prosthetic joint infections using (99m)Tc-antigranulocyte SPECT/CT: initial clinical results. Eur J Nucl Med Mol Imaging 2010;37:1751–9.PubMedCrossRef

24.

Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998;39:2145–52.PubMed

25.

Kaim A, Maurer T, Ochsner P, Jundt G, Kirsch E, Mueller-Brand J. Chronic complicated osteomyelitis of the appendicular skeleton: diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphy. Eur J Nucl Med 1997;24:732–8.PubMed

26.

Kroiss A, Böck F, Perneczky G, Auinger C, Weidlich G, Kleinpeter G, et al. Immunoscintigraphy for the detection of inflammation foci in bone and joint diseases. Wien Klin Wochenschr 1990;102:713–7.PubMed

27.

Hotze AL, Briele B, Overbeck B, Kropp J, Gruenwald F, Mekkawy MA, et al. Technetium-99m-labeled anti-granulocyte antibodies in suspected bone infections. J Nucl Med 1992;33:526–31.PubMed

28.

Reuland P, Winker KH, Heuchert T, Ruck P, Müller-Schauenburg W, Weller S, et al. Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J Nucl Med 1991;32:2209–14.PubMed

29.

Steinsträsser A, Oberhausen E. Granulocyte labelling kit BW 250/183–results of the European multicenter trial. Nuklearmedizin 1996;35:1–11.PubMed

30.

Boubaker A, Delaloye AB, Blanc CH, Dutoit M, Leyvraz PF, Delaloye B. Immunoscintigraphy with antigranulocyte monoclonal antibodies for the diagnosis of septic loosening of hip prostheses. Eur J Nucl Med 1995;22:139–47.PubMedCrossRef

31.

Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H, et al. Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. J Nucl Med 1994;35:1436–43.PubMed

Title: 99mTc-besilesomab (Scintimun®) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells
Authors: Wolf S. Richter
Velimir Ivancevic
Johannes Meller
Otto Lang
Dominique Le Guludec
István Szilvazi
Holger Amthauer
Florence Chossat
Amel Dahmane
Carsten Schwenke
Alberto Signore
Publication date: 01-05-2011
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-011-1731-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

^99mTc-besilesomab (Scintimun®) in peripheral osteomyelitis: comparison with ^99mTc-labelled white blood cells

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2011

Does hybrid diagnostic imaging in cardiology have the same significance as in oncology?

FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival

The effect of patient positioning aids on PET quantification in PET/MR imaging

PET/CT for staging lung cancer: costly or cost-saving?

In vivo imaging of immune cell trafficking in cancer

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine